-
Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Given Consensus Rating of "Moderate Buy" by Analysts
Источник: Buzz FX / 14 ноя 2024 03:11:19 America/New_York
Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Given Consensus Rating of "Moderate Buy" by Analysts Written by MarketBeat November 14, 2024 Share Link copied to clipboard. Shares of Crinetics Pharmaceuticals, Inc.
Read more...